EPS Creative Health Technology Group Limited (3860) announced a projected loss of approximately HK$3 million for the six months ended 30 September 2025, a stark contrast to the profit of about HK$17.1 million for the same period in 2024. According to the unaudited consolidated management accounts, the downturn was primarily driven by a decrease in fair value gain on a promissory note due to non-controlling interests and lower government grants.

The interim results have yet to undergo auditing or review by the auditor or the audit committee and are subject to potential changes. The final results are expected to be released in late November 2025. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.